Thema
Journal Article
159
Research Support, N.I.H., Extramural
102
Research Support, Non-U.S. Gov't
78
Antibodies, Viral
54
SARS-CoV-2
36
570
35
Biology
35
COVID-19 Vaccines
33
T cells
33
Antibodies, Neutralizing
29
Epitopes, T-Lymphocyte
28
COVID-19
26
Preprint
26
Spike Glycoprotein, Coronavirus
25
spike protein, SARS-CoV-2
21
82115-62-6
15
Interferon-gamma
15
Epitopes
14
Review
13
Antigens, Viral
12
Cytokines
11
Immunoglobulin G
11
Peptides
11
Viral Vaccines
11
vaccines
11
dengue virus
10
epitopes
10
CD4
9
Vaccines, Attenuated
8
BNT162 Vaccine
7
CD4+ T cells
7
Dengue Vaccines
7
HLA
7
cross-reactivity
7
615
6
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
6
C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000)
6
C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000)
6
CoronaVac
6
HLA Antigens
6
Immunodominant Epitopes
6
N38TVC63NU
6
Published Erratum
6
Research Support, U.S. Gov't, Non-P.H.S.
6
Viral Proteins
6
bio
6
che
6
epitope
6
vaccination
6
vaccine
6
mehr ...